Unique ID issued by UMIN | UMIN000018903 |
---|---|
Receipt number | R000021876 |
Scientific Title | Clinical evaluation of dietary intake of tomato juice in preventing ultraviolet-induced (UV) erythema formation in Japanese subjects |
Date of disclosure of the study information | 2015/09/05 |
Last modified on | 2016/03/04 03:56:11 |
Clinical evaluation of dietary intake of tomato juice in preventing ultraviolet-induced (UV) erythema formation in Japanese subjects
Preventive effect of tomato juice on UV-induced erythema in Japanese
Clinical evaluation of dietary intake of tomato juice in preventing ultraviolet-induced (UV) erythema formation in Japanese subjects
Preventive effect of tomato juice on UV-induced erythema in Japanese
Japan |
UV-induced erythema
Dermatology | Aesthetic surgery | Adult |
Others
NO
This study aims to demonstrate the efficacy of dietary intake of tomato juice in preventing UV-induced erythema in Japanese subjects, and confirm the contribution of lycopene to the effect.
Efficacy
Erythema formation induced by UV radiation at 0, 8, and 12 weeks after beginning the study
Increased level of malondialdehyde in stratum corneum, increased pigmentation, and changes in serum carotenoids (lycopene, beta-carotene, etc. and vitamin E)
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Dose comparison
YES
3
Prevention
Food |
tomato juice (once a day for 12 weeks)
Lycopene-rich tomato juice (once a day for 12 weeks)
Placebo (once a day for 12 weeks)
25 | years-old | <= |
50 | years-old | > |
Male and Female
1) Healthy Japanese Subjects
2) Subjects whose skin will sunburn (form erythema) easily and develop a tan by UV irradiation
1) Subjects with apparent pigmentation, inflammation, and other diseases in the inside of both upper arms
2) Subjects with history of photo sensitivity
3) Subjects who habitually consume tomato juice or lycopene-rich foods
4) Subjects who use pharmaceuticals and quasi-drugs effective in the treatment of UV-induced skin pigmentation and chloasma
5) Female subjects who is breast-feeding or in pregnancy, or plan to get pregnant during this study period
6) Subjects with risk of allergy regarding to this study
7) Subjects with smoking habit
8) Subjects who habitually consume higher amount of alcohol (> avg 60 g alcohol/day)
9) Subjects who participated in other clinical trials within 2 months.
10) Subjects who are judged unsuitable for this study by principal investigator and doctors.
75
1st name | |
Middle name | |
Last name | Hiroyuki Suganuma |
Kagome Co., Ltd.
Research & Development Division
17 Nishitomiyama, Nasushiobara, Tochigi 3292762, Japan
0287-36-2935
Hiroyuki_Suganuma@kagome.co.jp
1st name | |
Middle name | |
Last name | Kazunori Takashima |
Inforward, Inc
Ebisu Skin Research Center
1-11-2 Ebisu, Shibuya, Tokyo 1500013, Japan
03-5447-6411
takashima@inforward.co.jp
Kagome Co. Ltd.
None
Self funding
Inforward, Inc
NO
株式会社インフォワード恵比寿スキンリサーチセンター(東京都)
Ebisu Skin Research Center, Inforward, Inc (Tokyo)
2015 | Year | 09 | Month | 05 | Day |
Unpublished
Completed
2015 | Year | 08 | Month | 04 | Day |
2015 | Year | 09 | Month | 10 | Day |
2015 | Year | 09 | Month | 03 | Day |
2016 | Year | 03 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021876